Abstract:OBJECTIVE:To study the extent and incidence of sensorineural hearing loss (SNHL) after radiotherapy (RT). METHODS:Twenty-eight patients with diagnosed nasopharyngeal carcinoma (NPC) were selected. The pure-tone audiography, auditory brain stem evoked response (ABR), impedance audiometry and evoked otoacoustic emissions (EOAE) recordings were performed before RT, 1 month, 1, 2 and 5 years after RT. RESULTS:At 1 month after RT, there were 7.1 and 25.7 dB increased mean bone conduction (BC) thresholds at speech (0.5 - 4.0 kHz) and at high frequency (8.0 kHz), and their BC thresholds were statistically significant increase than those before RT, respectively (P < 0.001). At 1 year after RT, there were 17.6 and 28.1 dB increased respectively, and their thresholds were statistically significant increase than those at pre-irradiation (P < 0.001). There were also significant increases in thresholds than those at 1 month of post-irradiation (P <0.001 or P < 0.05). At 2 years after RT, 21 and 27.4 dB were increased at respective those two frequencies, and there was a statistically difference only at speech frequencies when compared with those at 1 year after RT (P < 0.05). At 5 years after RT, 26.7 and 35.8 dB were increased at these two frequencies, and there were significant increases in threshold than those before, 1 month, 1 and 2 years after RT, respectively (P < 0.001). From 1 month to 5 years after RT, 37. 5% to 94. 7% of ears had a BC hearing threshold of at least 15 dB losses at speech frequency, whereas the percentage at high frequency was 85.4 to 97.4%. Up to 63.2% and 73.7% of ears had 30 dB SNHL at least at speech and high frequency, respectively. Furthermore, the degree of mean threshold loss was greater at high frequency than at speech frequency. The mean value of wave I, III and V latency, and I -V interpeak latency intervals of ABR had no significant difference between at 1 month after RT and before RT (P > 0.05). The wave I , III and V latency, and I - V interpeak latency intervals at 1 year and 2 years were significantly prolonged when compared with those before and 1 month after RT (P < 0.05), but there were no significant difference between 1 year and 2 years after RT (P > 0.05). The wave I, III and V latency, and I -V interpeak latency intervals at 5 years after RT were also significantly longer than those before RT (P < 0.001). There were significant difference in wave I , III and V latency (P < 0.05), and no significant difference in wave I - V interpeak latency intervals (P > 0. 05) between 5 years after RT and 1 year or 2 years after RT. Seven of 10 ears at 1 year after RT and 4 of 7 ears at 5 years after RT had normal EOAE, but they all had abnormal ABR response. CONCLUSIONS:SNHL in NPC patients start soon after completion of RT, especially more commonly in high frequency. The incidence and the extent of hearing loss are increased with time of follow-up. The hearing impairment could occur in the cochlea and/or the retrocochlear auditory pathway, which show that the sensitivity of radiation damage may be different in different patient and anatomic site of auditory system.

Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.

[Clinical Observation of Sensorineural Hearing Loss in Patients Suffering from Nasopharyngeal Carcinoma after Radiotherapy].

~1H-MRS study on radiation-induced injury of the brain in early acute reaction stage after nasopharyngeal carcinoma radiotherapy

Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin

Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma

Dosimetric Parameters Associated with Conductive or Sensorineural Hearing Loss 5 Years after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma

Impacts on Hearing in Patients with Nasopharyngeal Cancer by Helical Tomotherapy and chemotherapy and /or Molecular-Targeted Therapy

Changes in Brain Gray Matter Volume in Nasopharyngeal Carcinoma Patients after Radiotherapy in Long-Term Follow-Up.

Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma survivors

Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic Therapy

Is the Risk of Idiopathic Sudden Sensorineural Hearing Loss Higher in Nasopharyngeal Carcinoma Than in Hypopharyngeal Cancer? A Population-Based Study.

Study of secretory otitis media after radiotherapy in nasopharyngeal carcinoma and inquisition of prevention and treatment

Long-term Effect on Auditory Brain Stem Function of Patients with Nasopharyngeal Carcinoma after Radiotherapy

The influences and treatments of deafness in nasopharyngeal carcinoma patients after radiotherapy

Related Factors of Sinusitis after Radiotherapy for Nasopharyngeal Carcinoma

Changes of Visual Field and Visual Evoked Potential in Nasopharyngeal Carcinoma Patients after Radiotherapy

Effect of Hydrogen Inhalation Therapy on Hearing Loss of Patients With Nasopharyngeal Carcinoma After Radiotherapy

[Change in Visual Evoked Potential by Radiotherapy of Nasopharyngeal Carcinoma].

Evaluation and Analysis of Risk Factors of Hearing Impairment for Nasopharyngeal Carcinoma Treated Using Intensity-Modulated Radiotherapy.

[Important Prognostic Factors in Patients with Skull Base Erosion from Nasopharyngeal Carcinoma after Radiotherapy].

The clinical study of carotid stenosis after radiotherapy in nasopharyngeal carcinoma